Ophthotech Corp Logo Image

Ophthotech Corp

Ophthotech Corp Banner Image

Most Recent Annual Report

2017 Annual Report and Form 10K

Ophthotech Corp

Ophthotech Corp has reached its limit for free report views.

Ophthotech Corp does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Ophthotech Corp

51-200 Employees
Based in New York, New York

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of back of the eye. Its principal product candidate, Fovista, is in Phase III clinical development for use in combination with anti-VEGF drugs for the treatment of wet age-related macular degeneration (AMD).

Ticker:
OPHT
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol